1-3 of 3
Cynthia Toze
Close
Sort by
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

Cynthia Toze, MD, FRCPC, Chinmay B. Dalal, MD, Tanya L. Gillan, PhD, FCCMG, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna E. Hogge, MD, PhD, Donna L. Forrest, MD, Heather Sutherland, MD, PhD, FRCPC, Kevin Song, MD, Raewyn Broady, MBChB, FRACP, Maryse Power, MD, FRCPath, Sujaatha Narayanan, MD, Clayton A. Smith, MD, FRCPC, John Shepherd
Journal: Blood
Blood (2010) 116 (21): 3465.
https://doi.org/10.1182/blood.V116.21.3465.3465
Published: 2010
Journal Articles

The Use of Novel Agents In Patients with Multiple Myeloma Initially Treated with Allogeneic Stem Cell Transplantation Results In A Significant Prolongation of Post Relapse Survival.

Christopher P. Venner, MD, Heather Sutherland, MD, PhD, FRCPC, John Shepherd, MD, FRCPC, Yasser Abou Mourad, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Janet Nitta, Maryse Power, MD, FRCPath, Cynthia Toze, MD, FRCPC, Clayton Smith, Kevin Song, MD
Journal: Blood
Blood (2010) 116 (21): 4580.
https://doi.org/10.1182/blood.V116.21.4580.4580
Published: 2010
Journal Articles

Induction Therapy with High-Dose Dex Alone in Newly Diagnosed Myeloma Patients Produces a 57% Partial Response and Is Predictive of Progression Free Survival.

David A. Irvine, Michael J. Barnett, Ryan Brinkman, Donna L. Forrest, Donna E. Hogge, Julye Lavoie, Linda Lei, Stephen H. Nantel, Thomas J. Nevill, Janet Nitta, John Shepherd, Kevin Song, Cynthia Toze, Heather Sutherland
Journal: Blood
Blood (2006) 108 (11): 3098.
https://doi.org/10.1182/blood.V108.11.3098.3098
Published: 2006